Antineoplastic mkpọ-rhG-CSF Ọgwụ
Short Description:
Product Description
Antineoplastic mkpọ-rhG-CSF Ọgwụ for the patients of non-myeloablative malignancy with the treatment of antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia. Antineoplastic mkpọ-rhG-CSF Ọgwụ na-adịghị eji maka nchikota ndi mmadu di nke elu ọbara progenitor cell maka hematopoietic azuokokoosisi cell transplantation.
Drug Name
Ọnyà Name. PEGylated Recombinant Human Granulocyte Colony ume lekọtara Ọgwụ
English Name. PEGylated Recombinant Human Granulocyte Colony ume lekọtara Ọgwụ
Antineoplastic mkpọ-rhG-CSF Ọgwụ Description
doro anya mmiri mmiri
Antineoplastic mkpọ-rhG-CSF Ọgwụegosi
1. Ọ na-eji maka ndị ọrịa nke na-abụghị myeloablative malignancy na ọgwụgwọ nke antineoplastic, mgbe nwere ike ọgwụ pụtara febrile neutrophilic belata myelosuppression, iji ngwaahịa a iji belata omume ọnụego nke ọrịa mere site febrile neutropenia.
2. Nke a ngwaahịa na-adịghị eji maka nchikota ndi mmadu di nke elu ọbara progenitor cell maka hematopoietic azuokokoosisi cell transplantation.
Antineoplastic mkpọ-rhG-CSF Ọgwụ Contraindication
Ọ na-aju maka anabata mkpọ-rhG-CSF, rhG-CSF na e.coli ngosipụta nke ọzọ preparations.The ọrịa na serous imeju, akụrụ, obi, akpa ume dysfunction bụ nkwarụ.
Antineoplastic mkpọ-rhG-CSF Ọgwụ Product Photos
Antineoplastic mkpọ-rhG-CSF Ọgwụ Transportation na Ịkwụ Ụgwọ Okwu 
nkọwapụta 3 mg/ml
packaging 1 bottle/box
preparations injection
